Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele

Autor: Paul C. Van Ness, Ramon Diaz-Arrastia, Yunhua Gong, Kristin D. Scott, Mark Agostini, Maria C. Garcia, Suzette Fair, Mary C. Carlile
Rok vydání: 2003
Předmět:
Zdroj: Archives of neurology. 60(6)
ISSN: 0003-9942
Popis: Background Late posttraumatic seizures are a common complication of moderate and severe traumatic brain injury. Inheritance of the apolipoprotein E (APOE) ϵ 4 allele is associated with increased risk of Alzheimer disease, progression to disability in multiple sclerosis, and poor outcome after traumatic brain injury. Objective To determine whether inheritance of APOE ϵ 4 is associated with increased risk of developing late posttraumatic seizures. Design Prospective study. Setting Neurosurgical service at an urban level I trauma center. Patients Patients admitted with a diagnosis of moderate and severe traumatic brain injury were enrolled. Methods Six months after injury, patients were contacted to determine functional outcome (according to the Glasgow Outcome Scale–Expanded [GOS-E]) and the presence of late posttraumatic seizures. Genotype at the APOE locus was determined by restriction fragment length polymorphism analysis. Results DNA and outcome information was obtained from 106 subjects. Six months after injury, 31 (29%) had a poor outcome (GOS-E score, 1-4), 47 (44%) had an intermediate outcome (GOS-E score, 5-6), and 28 (26%) had a favorable outcome (GOS-E score, 7-8). Twenty-one patients (20%) had at least 1 late posttraumatic seizure. The relative risk of late posttraumatic seizures for patients with the ϵ 4 allele was 2.41 (95% confidence interval, 1.15-5.07; P = .03). In this cohort, inheritance of APOE ϵ 4 was not associated with an unfavorable GOS-E score 6 ( P = .47). Conclusions Inheritance of the APOE ϵ 4 allele is associated with increased risk of late posttraumatic seizures. In this cohort, this risk appears to be independent of an effect of ϵ 4 on functional outcome. A better understanding of the molecular role of APOE in neurodegenerative diseases may be helpful in developing antiepileptogenic therapies.
Databáze: OpenAIRE